The National Academies of Sciences, Engineering, and Medicine Committee on Evidence-based Clinical Practice Guidelines for Prescribing Opioids for Acute Pain will host a Feb. 4 public workshop as part of its information gathering activities. The Food and Drug Administration last year awarded NASEM a contract to develop evidence-based guidelines for appropriate opioid prescribing for acute pain. The workshop will feature presentations and panel discussions on surgical procedures and medical conditions associated with acute pain, and identifying and using evidence to inform the guidelines. To attend the workshop in person or via webcast, register here. AHA is a member of the National Academy of Medicine Action Collaborative on Countering the U.S. Opioid Epidemic, a public-private partnership that will develop and disseminate evidence-based solutions to reduce opioid misuse and improve outcomes for individuals, families and communities affected by addiction.
 

Related News Articles

Headline
The House Committee on Oversight and Reform today held the third in a series of hearings examining solutions to the opioid epidemic, which focused on the…
Headline
The Food and Drug Administration today published a notice seeking comment through July 30 on a potential change to the Opioid Analgesic Risk Evaluation and…
Headline
The Health Resources and Services Administration yesterday awarded 120 organizations, including hospitals, $200,000 each to develop community partnerships and…
Headline
Laws that allow pharmacists to dispense the opioid antidote naloxone without a physician’s prescription are associated with a sharp reduction in fatal opioid-…
Headline
The White House Office of National Drug Control Policy seeks by 2022 to reduce drug overdose deaths and youth illicit drug use by 15 percent and opioid…
Perspective
Investing in our country’s health infrastructure is the right move to make.